Genmab — September 2023
-
Genmab-partner har positive resultater i lungekræftstudie https://www.proinvestor.com/investornyt/1056126/genmab-partner-har-positive-resultater-i-lungekraeftstudie
-
De drypper løbende ind gennem mine Ugekommentarer og podcast m.m. Intet nyt under solen. Investorer over en bred kam søger andre græsgange end f.eks. biotek. Det uagtet hvor modnede selskaberne er.
-
Zealand Pharma-casen er i den sammenhæng helt speciel. Fedmesegmentet er pt. i en helt unik stærk position.
-
Det var så lidt Klarussen. Disclaimer: Jeg er stadig en meget tålmodighed aktionær i Genmab.
-
-
Ja, jeg må jo nok give samme disclaimer som @Helge 19:40. Jeg har været i aktien siden feb. 2015. Har alene solgt småbidder til betaling af PAL skat. Men jeg ønsker også at være en aktiv debattør - og da går man jo af og til, lidt tæt på
-
Grant of Restricted Stock Units and Warrants to Employees in Genmab https://www.proinvestor.com/investornyt/1056192/grant-of-restricted-stock-units-and-warrants-to-employees-in-genmab
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind